Transient Global Amnesia (TGA) Clinical Trial
— 2NIAOfficial title:
Neuropsycholgy and Neuroimaging in Transient Global Amnesia
| Verified date | November 2015 |
| Source | University Hospital, Caen |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to establish a diagnosis in transient global amnesia (TGA) in assessing three episodic memory's abilities (mental simulation throught the future, and the past, the learning of personnal actions i-e the enactment effect). Secondary goal is to describe the neuronal substrates associated to the alteration of theses abilites in TGA.
| Status | Terminated |
| Enrollment | 60 |
| Est. completion date | December 2015 |
| Est. primary completion date | July 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 30 Years to 90 Years |
| Eligibility |
Inclusion Criteria: - All the participants - Minimum of 7 years of education - French native speaker - Healthy subjects : Non pathological Dementia rating scale score - Patients : Clinical diagnosis of TGA according to Hodges and Warlow's criterion Exclusion Criteria: - Chronic neurological disease - Encephalitis - Endocrinal disease - Hepatic disease - Case history of head injury with loss of consciousness of more than one hour - Case history of stroke - Case history of cancer during the five last years except squamous cell carcinomas - Alcoholism or drug addiction - Major psychiatric disorders according the Diagnostic and Statistical Manual of -Mental Disorders |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Caen |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Episodic memory scores | 3 years |